Fayez Sarofim & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $819K | Hold |
10,477
| – | – | ﹤0.01% | 200 |
|
2025
Q1 | $759K | Sell |
10,477
-3,278
| -24% | -$238K | ﹤0.01% | 205 |
|
2024
Q4 | $1.02M | Sell |
13,755
-210
| -2% | -$15.5K | ﹤0.01% | 185 |
|
2024
Q3 | $922K | Hold |
13,965
| – | – | ﹤0.01% | 179 |
|
2024
Q2 | $1.29M | Hold |
13,965
| – | – | ﹤0.01% | 159 |
|
2024
Q1 | $1.33M | Hold |
13,965
| – | – | ﹤0.01% | 156 |
|
2023
Q4 | $1.19M | Sell |
13,965
-1,598
| -10% | -$136K | ﹤0.01% | 156 |
|
2023
Q3 | $1.08M | Sell |
15,563
-2,500
| -14% | -$173K | ﹤0.01% | 165 |
|
2023
Q2 | $1.7M | Sell |
18,063
-705
| -4% | -$66.5K | 0.01% | 149 |
|
2023
Q1 | $1.55M | Sell |
18,768
-105
| -0.6% | -$8.69K | 0.01% | 159 |
|
2022
Q4 | $1.41M | Hold |
18,873
| – | – | 0.01% | 155 |
|
2022
Q3 | $1.56M | Hold |
18,873
| – | – | 0.01% | 154 |
|
2022
Q2 | $1.8M | Sell |
18,873
-460
| -2% | -$43.8K | 0.01% | 150 |
|
2022
Q1 | $2.28M | Hold |
19,333
| – | – | 0.01% | 150 |
|
2021
Q4 | $2.51M | Sell |
19,333
-643
| -3% | -$83.3K | 0.01% | 152 |
|
2021
Q3 | $2.26M | Hold |
19,976
| – | – | 0.01% | 148 |
|
2021
Q2 | $2.07M | Sell |
19,976
-3,560
| -15% | -$369K | 0.01% | 157 |
|
2021
Q1 | $1.97M | Buy |
23,536
+3,430
| +17% | +$287K | 0.01% | 143 |
|
2020
Q4 | $1.83M | Hold |
20,106
| – | – | 0.01% | 144 |
|
2020
Q3 | $1.61M | Buy |
20,106
+422
| +2% | +$33.7K | 0.01% | 143 |
|
2020
Q2 | $1.36M | Buy |
19,684
+2,578
| +15% | +$178K | 0.01% | 145 |
|
2020
Q1 | $1.08M | Hold |
17,106
| – | – | 0.01% | 145 |
|
2019
Q4 | $1.33M | Buy |
17,106
+3,729
| +28% | +$290K | 0.01% | 152 |
|
2019
Q3 | $981K | Buy |
13,377
+3,627
| +37% | +$266K | 0.01% | 163 |
|
2019
Q2 | $600K | Buy |
9,750
+570
| +6% | +$35.1K | ﹤0.01% | 179 |
|
2019
Q1 | $585K | Buy |
9,180
+420
| +5% | +$26.8K | ﹤0.01% | 177 |
|
2018
Q4 | $447K | Sell |
8,760
-420
| -5% | -$21.4K | ﹤0.01% | 185 |
|
2018
Q3 | $533K | Hold |
9,180
| – | – | ﹤0.01% | 182 |
|
2018
Q2 | $445K | Buy |
+9,180
| New | +$445K | ﹤0.01% | 191 |
|